Drug
KLU156 clinical trials
Also written KLU156.
- studies test it
- 4
- open now
- 2
- in phase 3
- 1
- first study started
- 2024
Keep track of what changes. Save the KLU156 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2024 (3)
| Year | Studies |
|---|---|
| 2024 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses KLU156 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)RecruitingPhase 2Novartis PharmaceuticalsNCT07811908Written as KLU156
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaRecruitingPhase 2Novartis PharmaceuticalsNCT05750628Written as KLU156
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2)CompletedPhase 2Novartis PharmaceuticalsNCT07235033Written as KLU156
- Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaCompletedPhase 3Novartis PharmaceuticalsNCT05842954Written as KLU156